Phosphodiesterase-5 is Elevated in Failing Single Ventricle Myocardium and Affects Cardiomyocyte Remodeling in vitro

BACKGROUND: Single ventricle congenital heart disease (SV) is fatal without intervention and eventual heart failure (HF) is a major cause of morbidity and mortality. While there are no proven medical therapies for the treatment or prevention of HF in the SV population, phosphodiesterase-5 inhibitors...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Circ Heart Fail
Auteurs principaux: Garcia, Anastacia M., Nakano, Stephanie J., Karimpour-Fard, Anis, Nunley, Karin, Blain-Nelson, Penny, Stafford, Natalie M., Stauffer, Brian L, Sucharov, Carmen C., Miyamoto, Shelley D.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206883/
https://ncbi.nlm.nih.gov/pubmed/30354365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004571
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires